PMID- 36285160
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230818
IS  - 1741-427X (Print)
IS  - 1741-4288 (Electronic)
IS  - 1741-427X (Linking)
VI  - 2022
DP  - 2022
TI  - Noncoding RNAs and Virus and Treatment in Allergic Rhinitis.
PG  - 1979447
LID - 10.1155/2022/1979447 [doi]
LID - 1979447
AB  - Allergic rhinitis (AR) is a type I hypersensitivity reaction disease caused by 
      inhaled allergens and immunoglobulin E (IgE)-mediated. Noncoding RNA (ncRNA) is 
      an important regulator involved in gene expression and can be detected in the 
      cytoplasm or extracellular fluid, which mainly includes microRNAs (miRNA, length 
      22-24 nucleotides), long noncoding RNAs (lncRNA, length >200 nucleotides), and 
      circRNAs. LncRNA and miRNA both participate in the regulation of immune function. 
      Some respiratory viral infections can aggravate allergic rhinitis, such as a 
      respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). However, the 
      interaction between viral infection and allergy is complex and the mechanism is 
      still unclear. In this review, we summarized the interactions of noncoding RNAs 
      and viruses in the occurrence and development of AR, along with the treatments 
      focusing on the noncoding RNAs in the past five years.
CI  - Copyright (c) 2022 Zhu Lei et al.
FAU - Lei, Zhu
AU  - Lei Z
AD  - Otolaryngology Department, Xianning First People's Hospital, Xianning 437100, 
      Hubei, China.
FAU - Feng, Guangrui
AU  - Feng G
AD  - Cardiovascular Medicine Department, The First Affiliated Hospital of Hubei 
      University of Science and Technology, Xianning 437100, Hubei, China.
FAU - Wang, Zhiguo
AU  - Wang Z
AD  - Dermatology Department, The First Affiliated Hospital of Hubei University of 
      Science and Technology, Xianning 437100, Hubei, China.
FAU - Ning, Zhifeng
AU  - Ning Z
AUID- ORCID: 0000-0001-9869-5928
AD  - Human Anatomy Department, Basic Medicine College, Hubei University of Science and 
      Technology, Xianning 437100, Hubei, China.
LA  - eng
PT  - Journal Article
PT  - Retracted Publication
DEP - 20221015
PL  - United States
TA  - Evid Based Complement Alternat Med
JT  - Evidence-based complementary and alternative medicine : eCAM
JID - 101215021
RIN - Evid Based Complement Alternat Med. 2023 Aug 9;2023:9898150. PMID: 37593036
PMC - PMC9588333
COIS- The authors declare that they have no conflicts of interest.
EDAT- 2022/10/27 06:00
MHDA- 2022/10/27 06:01
PMCR- 2022/10/15
CRDT- 2022/10/26 02:13
PHST- 2022/07/01 00:00 [received]
PHST- 2022/07/31 00:00 [revised]
PHST- 2022/08/17 00:00 [accepted]
PHST- 2022/10/26 02:13 [entrez]
PHST- 2022/10/27 06:00 [pubmed]
PHST- 2022/10/27 06:01 [medline]
PHST- 2022/10/15 00:00 [pmc-release]
AID - 10.1155/2022/1979447 [doi]
PST - epublish
SO  - Evid Based Complement Alternat Med. 2022 Oct 15;2022:1979447. doi: 
      10.1155/2022/1979447. eCollection 2022.